Keith Barton is a glaucoma and cataract surgeon at Moorfields Eye Hospital in London and Professor of Ophthalmology at University College London specialising in the surgical management of advanced and secondary glaucoma.

 


Glaucoma Surgical Innovation & Glaucoma Surgical Research

Specifically, Keith has pioneered the use of a number of glaucoma surgical techniques including the Baerveldt Glaucoma Implant, Xen Gel Implant, Preserflo Microshunt, and Cypass Micro-stent. He is a co-inventor of the Paul Glaucoma Implant and is a Scientific Advisory Board member of ELIOS Vision, Myra Vision, and EyeD Pharma.

Keith was also a trial management group member of the NIHR-funded LigHT and TAGS trials, as well as a steering group member of the landmark Tube Versus Trabeculectomy and Primary TVT studies and co-chair of the Ahmed Baerveldt Comparison study.

 


Achievements & Honours

In 2024, Keith was awarded the International Scholar Award by the American Glaucoma Society and voted one of the 100 most influential ophthalmologists in the world for the 5th time by The Ophthalmologist Magazine and in the global top 10 for the second time.

In October, he will give the Francisco Fantes Memorial Lecture on glaucoma surgery at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

 


Special Tributes

A special tribute from a very special patient, click here for the video tribute.

 


Educational Resources, Conference & Innovation Forums

Online surgical video channels, lectures, conferences and industry investor forums, run by Keith Barton. Click here for more information.

Keith co-founded and co-organises Ophthalmology Futures Forums and founded, organises, and runs the annual Moorfields International Glaucoma Symposium, MIGS.org, a website offering commercially independent patient information on glaucoma surgery, and the International Glaucoma Surgery Registry.

 


Further Information

For further information on Keith’s activities and achievements, visit his about page.